Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Pluri Inc.
PLURCurrent price
5.2 USD
-0.27 USD (-5.02%)
Last closed
5.68 USD
Company
pluri-biotech.com
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
28 830 026 USD
Yield for 12 month
+3.09 %
1Y
3Y
5Y
10Y
15Y
PLUR
Pluri Inc., a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production. The company's development pipeline includes PLX-PAD, is composed of maternal mesenchymal stromal cells originating from the placenta that is currently under phase III study for orthopedic, phase II study for COVID-19, and phase I/II clinical study for Steroid-Refractory cGVHD indications; and PLX-R18, is composed of fetal MSC like cells originating from the placenta that is currently under phase I study for HCT and pilot study for ARS indications. It is also involved in the development of modified PLX cells. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel. Address: Building No. 5, Haifa, Israel, 3508409
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
4 USDP/E ratio
–Dividend Yield
–Current Year
+287 000 USD
Last Year
+234 000 USD
Current Quarter
+71 000 USD
Last Quarter
+105 000 USD
Current Year
+278 000 USD
Last Year
-41 359 000 USD
Current Quarter
+10 000 USD
Last Quarter
-5 108 000 USD
Key Figures PLUR
1 year
3 years
5 years
10 years
EBITDA
-22 399 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-30.59 %
PEG Ratio
–
Return On Equity TTM
-194.38 %
Wall Street Target Price
4 USD
Revenue TTM
341 000 USD
Book Value
-0.068 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-18.4 %
Dividend Yield
–
Gross Profit TTM
278 000 USD
Earnings per share
-4.12 USD
Diluted Eps TTM
-4.12 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics PLUR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PLUR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:8
Payout Ratio
–
Last Split Date
01.04.2024
Dividend Date
25.07.2019
Stock Valuation PLUR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
96.4986
Price Sales TTM
84.5455
Enterprise Value EBITDA
-1.2834
Price Book MRQ
6.8324
Financials PLUR
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PLUR
For 52 weeks
3.44 USD
8.48 USD
50 Day MA
5.53 USD
Shares Short Prior Month
11 089
200 Day MA
5.65 USD
Short Ratio
1.57
Shares Short
10 387
Short Percent
0.22 %
BeatStart